Overactive bladder-18 years - Part II

Imagem de Miniatura
Arquivos
art_TRUZZI_Overactive_bladder18_years_Part_II_2016.PDF (199.15 KB)
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Autores
TRUZZI, Jose Carlos
BEZERRA, Carlos A.
PLATA, Ivan Mauricio
CAMPOS, Jose
GARRIDO, Gustavo Luis
ALMEIDA, Fernando G.
AVERBECK, Marcio Augusto
FORNARI, Alexandre
SALAZAR, Anibal
Citação
INTERNATIONAL BRAZ J UROL, v.42, n.2, p.199-214, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Traditionally, the treatment of overactive bladder syndrome has been based on the use of oral medications with the purpose of reestablishing the detrusor stability. The recent better understanding of the urothelial physiology fostered conceptual changes, and the oral anticholinergics - pillars of the overactive bladder pharmacotherapy - started to be not only recognized for their properties of inhibiting the detrusor contractile activity, but also their action on the bladder afference, and therefore, on the reduction of the symptoms that constitute the syndrome. Beta-adrenergic agonists, which were recently added to the list of drugs for the treatment of overactive bladder, still wait for a definitive positioning - as either a second-line therapy or an adjuvant to oral anticholinergics. Conservative treatment failure, whether due to unsatisfactory results or the presence of adverse side effects, define it as refractory overactive bladder. In this context, the intravesical injection of botulinum toxin type A emerged as an effective option for the existing gap between the primary measures and more complex procedures such as bladder augmentation. Sacral neuromodulation, described three decades ago, had its indication reinforced in this overactive bladder era. Likewise, the electric stimulation of the tibial nerve is now a minimally invasive alternative to treat those with refractory overactive bladder. The results of the systematic literature review on the oral pharmacological treatment and the treatment of refractory overactive bladder gave rise to this second part of the review article Overactive Bladder - 18 years, prepared during the 1st Latin-American Consultation on Overactive Bladder.
Palavras-chave
Overactive Bladder, Muscarinic Antagonists, Beta-adrenergic agonists, Botulinum Toxin, Sacral neuromodulation, Urodynamics
URI
https://observatorio.fm.usp.br/handle/OPI/14548
Referências
  1. Chapple C, 2013, EUR UROL, V64, P249, DOI 10.1016/j.eururo.2013.04.001
  2. Angioli R, 2013, INT UROGYNECOL J, V24, P789, DOI 10.1007/s00192-012-1928-3
  3. Abrams P, 2006, INT J UROL, V13, P692, DOI 10.1111/j.1442-2042.2006.01387.x
  4. Peeters K, 2014, BJU INT, V113, P789, DOI 10.1111/bju.12571
  5. Herschorn S, 2013, UROLOGY, V82, P1457, DOI 10.1016/j.urology.2013.02.077
  6. Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x
  7. Leong RK, 2011, NEUROUROL URODYNAM, V30, P1249, DOI 10.1002/nau.20979
  8. Igawa Y, 2013, N-S ARCH PHARMACOL, V386, P177, DOI 10.1007/s00210-012-0824-1
  9. Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045
  10. Haab F, 2004, EUR UROL, V45, P420, DOI 10.1016/j.eururo.2004.01.008
  11. Staskin DR, 2005, DRUG AGING, V22, P1013, DOI 10.2165/00002512-200522120-00003
  12. Khan S, 2009, J UROLOGY, V181, P1773, DOI 10.1016/j.juro.2008.11.110
  13. Chapple C, 2008, EUR UROL, V53, P1319, DOI 10.1016/j.eururo.2007.07.009
  14. Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6
  15. Murakami S, 2007, BJU INT, V99, P669, DOI 10.1111/j.1464-410X.2006.06679.x
  16. Ozdedeli S, 2010, CLIN REHABIL, V24, P342, DOI 10.1177/0269215509346092
  17. Biemans JMAE, 2013, NEUROMODULATION, V16, P25, DOI 10.1111/j.1525-1403.2012.00504.x
  18. Saks EK, 2009, OBSTET GYN CLIN N AM, V36, P493, DOI 10.1016/j.ogc.2009.08.001
  19. Steers W, 2005, BJU INT, V95, P1385, DOI 10.1111/j.1464-410X.2005.05600.x
  20. Appell RA, 2001, MAYO CLIN PROC, V76, P358
  21. Burgio KL, 2010, J UROLOGY, V184, P598, DOI 10.1016/j.juro.2010.03.141
  22. Chancellor M, 2000, CLIN DRUG INVEST, V19, P83, DOI 10.2165/00044011-200019020-00001
  23. Benner JS, 2010, BJU INT, V105, P1276, DOI 10.1111/j.1464-410X.2009.09036.x
  24. Birder LA, 2002, J NEUROSCI, V22, P8063
  25. Hegde SS, 2006, BRIT J PHARMACOL, V147, pS80, DOI 10.1038/sj.bjp.0706560
  26. MADERSBACHER H, 1995, BRIT J UROL, V75, P452, DOI 10.1111/j.1464-410X.1995.tb07264.x
  27. Groen LA, 2012, J UROLOGY, V188, P1313, DOI 10.1016/j.juro.2012.06.039
  28. Yazdany T, 2011, INT UROGYNECOL J, V22, P1549, DOI 10.1007/s00192-011-1512-2
  29. Homma Y, 2006, NEUROUROL URODYNAM, V25, P228, DOI 10.1002/nau.20195
  30. Malone-Lee J, 2001, J UROLOGY, V165, P1452, DOI 10.1016/S0022-5347(05)66326-4
  31. Denys P, 2012, EUR UROL, V61, P520, DOI 10.1016/j.eururo.2011.10.028
  32. Malone-Lee JG, 2001, J AM GERIATR SOC, V49, P700, DOI 10.1046/j.1532-5415.2001.49144.x
  33. Peters KM, 2013, NEUROUROL URODYNAM, V32, P24, DOI 10.1002/nau.22266
  34. Chapple CR, 2012, EUR UROL, V62, P841, DOI 10.1016/j.eururo.2012.08.006
  35. Siegel SW, 2000, UROLOGY, V56, P87, DOI 10.1016/S0090-4295(00)00597-5
  36. Chapple CR, 2004, BJU INT, V93, P303, DOI 10.1111/j.1464-410X.2004.04606.x
  37. Rackley R, 2006, UROLOGY, V67, P731, DOI 10.1016/j.urology.2005.10.061
  38. Nelken RS, 2011, MENOPAUSE, V18, P962, DOI 10.1097/gme.0b013e3182104977
  39. Zat'ura F, 2010, EUR UROL, V57, P145, DOI 10.1016/j.eururo.2009.04.045
  40. Leong RK, 2010, UROL INT, V84, P245, DOI 10.1159/000288223
  41. Stohrer M, 2007, EUR UROL, V51, P235, DOI 10.1016/j.eururo.2006.03.016
  42. Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P988, DOI 10.1111/j.1471-0528.1997.tb12054.x
  43. Flynn MK, 2009, J UROLOGY, V181, P2608, DOI 10.1016/j.juro.2009.01.117
  44. Noblett K, 2016, NEUROUROL URODYNAM, V35, P246, DOI 10.1002/nau.22707
  45. Jonas U, 1997, WORLD J UROL, V15, P144, DOI 10.1007/BF02201987
  46. Nitti VW, 2010, BJU INT, V105, P1268, DOI 10.1111/j.1464-410X.2009.09037.x
  47. Yoong W, 2013, INT UROGYNECOL J, V24, P795, DOI 10.1007/s00192-012-1936-3
  48. Diokno AC, 2003, MAYO CLIN PROC, V78, P687
  49. Mohee A, 2013, BJU INT, V111, P106, DOI 10.1111/j.1464-410X.2012.11282.x
  50. Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8
  51. Dmochowski RR, 2008, UROLOGY, V71, P449, DOI 10.1016/j.urology.2007.11.008
  52. Wagg A, 2013, EUR UROL, V64, P74, DOI 10.1016/j.eururo.2013.01.002
  53. Chapple CR, 2013, INT UROGYNECOL J, V24, P1447, DOI 10.1007/s00192-013-2042-x
  54. Hood B, 2013, INT J UROL, V20, P21, DOI 10.1111/j.1442-2042.2012.03196.x
  55. Marchal C, 2011, UROLOGY, V78, P1046, DOI 10.1016/j.urology.2011.07.1394
  56. Kanagarajah P, 2012, INT UROL NEPHROL, V44, P91, DOI 10.1007/s11255-011-9979-9
  57. Rovner E, 2011, NEUROUROL URODYNAM, V30, P556, DOI 10.1002/nau.21021
  58. Khullar V, 2013, EUR UROL, V63, P283, DOI 10.1016/j.eururo.2012.10.016
  59. Steers W, 2005, BJU INT, V95, P580, DOI 10.1111/j.1464-410X.2005.05343.x
  60. Amarenco G, 2003, J UROLOGY, V169, P2210, DOI 10.1097/01.ju.0000067446.17576.bd
  61. Yamaguchi O, 2014, BJU INT, V113, P951, DOI 10.1111/bju.12649
  62. Leung HY, 2002, BJU INT, V90, P375, DOI 10.1046/j.1464-4096.2002.02905.x
  63. Herschorn S, 2013, UROLOGY, V82, P313, DOI 10.1016/j.urology.2013.02.077
  64. Berghmans LCM, 2000, BJU INT, V85, P254, DOI 10.1046/j.1464-410x.2000.00434.x
  65. Novara G, 2008, EUR UROL, V54, P740, DOI 10.1016/j.eururo.2008.06.080
  66. Lackner TE, 2008, J AM GERIATR SOC, V56, P862, DOI 10.1111/j.1532-5415.2008.01680.x
  67. Giannitsas K, 2004, EUR UROL, V46, P776, DOI 10.1016/j.eururo.2004.07.021
  68. Saks EK, 2010, OBSTET GYN CLIN N AM, V37, P135, DOI 10.1016/j.ogc.2010.04.023
  69. Bhidayasiri R, 2006, EUR J NEUROL, V13, P21, DOI 10.1111/j.1468-1331.2006.01441.x
  70. Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995
  71. Granese R, 2012, ARCH GYNECOL OBSTET, V286, P923, DOI 10.1007/s00404-012-2349-8
  72. Arruda RM, 2008, INT UROGYNECOL J, V19, P1055, DOI 10.1007/s00192-008-0586-y
  73. Anderson RU, 2006, INT UROGYNECOL J, V17, P502, DOI 10.1007/s00192-005-0057-7
  74. Cardozo L, 2004, J UROLOGY, V172, P1919, DOI 10.1097/01.ju.0000140729.07840.16
  75. Rentzhog L, 1998, BRIT J UROL, V81, P42
  76. Dmochowski R, 2010, J UROLOGY, V184, P2416, DOI 10.1016/j.juro.2010.08.021
  77. Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x
  78. Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079
  79. Kay G, 2006, EUR UROL, V50, P317, DOI 10.1016/j.eururo.2006.03.057
  80. Herschorn S, 2010, BJU INT, V105, P58, DOI 10.1111/j.1464-410X.2009.09086.x
  81. Chapple CR, 2013, NEUROUROL URODYNAM, V32, P1116, DOI 10.1002/nau.22373
  82. Lee JG, 2002, INT J UROL, V9, P247, DOI 10.1046/j.1442-2042.2002.00460.x
  83. Kuo HC, 2010, EUR UROL, V58, P919, DOI 10.1016/j.eururo.2010.09.007
  84. Burton C, 2012, NEUROUROL URODYNAM, V31, P1206, DOI 10.1002/nau.22251
  85. Tseng LH, 2009, NEUROUROL URODYNAM, V28, P47, DOI 10.1002/nau.20583
  86. Zinner NR, 2002, J AM GERIATR SOC, V50, P799, DOI 10.1046/j.1532-5415.2002.50203.x
  87. Malik M, 2012, CLIN PHARMACOL THER, V92, P696, DOI 10.1038/clpt.2012.181
  88. Cameron AP, 2013, NEUROUROL URODYNAM, V32, P238, DOI 10.1002/nau.22294
  89. Santos-Silva A, 2013, INT J UROL, V20, P956, DOI 10.1111/iju.12188
  90. Sussman D, 2002, CURR MED RES OPIN, V18, P177, DOI 10.1185/03007990212500570
  91. Onal M, 2012, ARCH GYNECOL OBSTET, V286, P1453, DOI 10.1007/s00404-012-2464-6
  92. Govier FE, 2001, J UROLOGY, V165, P1193, DOI 10.1016/S0022-5347(05)66469-5
  93. Janknegt RA, 2001, EUR UROL, V39, P101, DOI 10.1159/000052420
  94. Millard R, 1999, J UROLOGY, V161, P1551, DOI 10.1016/S0022-5347(05)68951-3
  95. Yamaguchi O, 2007, BJU INT, V100, P579, DOI 10.1111/j.1464-410X.2007.07031.x
  96. Chapple C, 2007, CURR MED RES OPIN, V23, P2347, DOI 10.1185/03007X226294
  97. van Kerrebroeck PEV, 2007, J UROLOGY, V178, P2029, DOI 10.1016/j.juro.2007.07.032
  98. Sahai A, 2010, UROLOGY, V75, P552, DOI 10.1016/j.urology.2009.05.097
  99. Herschorn S, 2010, J UROLOGY, V183, P1892, DOI 10.1016/j.juro.2010.01.012
  100. Dmochowski RR, 2003, UROLOGY, V62, P237, DOI 10.1016/S0090-4295(03)00356-X
  101. Jacquetin B, 2001, EUR J OBSTET GYN R B, V98, P97, DOI 10.1016/S0301-2115(00)00561-3
  102. Amundsen CL, 2002, AM J OBSTET GYNECOL, V187, P1462, DOI 10.1067/mob.2002.130004
  103. Hijaz A, 2006, UROLOGY, V68, P533, DOI 10.1016/j.urology.2006.03.020
  104. Staskin D, 2007, J UROLOGY, V178, P978, DOI 10.1016/j.juro.2007.05.058
  105. Zinner N, 2004, J UROLOGY, V171, P2311, DOI 10.1097/01.ju.0000127742.73136.0c
  106. Anderson RU, 1999, J UROLOGY, V161, P1809, DOI 10.1016/S0022-5347(05)68810-6
  107. Rudy D, 2006, UROLOGY, V67, P275, DOI 10.1016/j.urology.2005.08.017
  108. Nitti VW, 2013, INT J CLIN PRACT, V67, P619, DOI 10.1111/ijcp.12194
  109. Khullar V, 2006, UROLOGY, V68, P38, DOI 10.1016/j.urology.2006.05.043
  110. Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000
  111. Wang AC, 2006, UROLOGY, V68, P999, DOI 10.1016/j.urology.2006.05.038
  112. Chapple CR, 2004, BJU INT, V93, P71, DOI 10.1046/j.1464-410X.2004.04561.x
  113. Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x
  114. Sand PK, 2004, INT UROGYNECOL J, V15, P243, DOI 10.1007/s00192-004-1161-9
  115. Hill S, 2006, INT UROGYNECOL J, V17, P239, DOI 10.1007/s00192-005-1340-3
  116. Spinelli M, 2003, J UROLOGY, V170, P1905, DOI 10.1097/01.ju.0000092634.64580.9a
  117. Song C, 2006, J KOREAN MED SCI, V21, P1060
  118. Abrams P, 2006, BRIT J PHARMACOL, V148, P565, DOI 10.1038/sj.bjp.0706780
  119. Robinson D, 2007, BJU INT, V100, P840, DOI 10.1111/j.1464-410X.2007.07162.x
  120. Vardy MD, 2009, INT J CLIN PRACT, V63, P1702, DOI 10.1111/j.1742-1241.2009.02209.x
  121. Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047
  122. Versi E, 2000, OBSTET GYNECOL, V95, P718, DOI 10.1016/S0029-7844(99)00661-4
  123. Nitti VW, 2013, J UROLOGY, V190, P1320, DOI 10.1016/j.juro.2013.05.062
  124. Frenkl TL, 2010, J UROLOGY, V184, P616, DOI 10.1016/j.juro.2010.03.147
  125. Sancaktar M, 2010, GYNECOL ENDOCRINOL, V26, P729, DOI 10.3109/09513591003649815
  126. Oefelein MG, 2011, DRUG SAFETY, V34, P733, DOI 10.2165/11592790-000000000-00000
  127. Barkin J, 2004, CLIN THER, V26, P1026, DOI 10.1016/S0149-2918(04)90174-9
  128. Chapple CR, 2013, EUR UROL, V63, P296, DOI 10.1016/j.eururo.2012.10.048
  129. Marcelissen T, 2011, J UROLOGY, V185, P583, DOI 10.1016/j.juro.2010.09.103
  130. Kay GG, 2012, CLIN DRUG INVEST, V32, P707, DOI 10.2165/11636310-000000000-00000
  131. Jonas U, 1997, WORLD J UROL, V15, P210, DOI 10.1007/BF02201860
  132. Abrams P, 1998, BRIT J UROL, V81, P801
  133. Nitti VW, 2013, J UROLOGY, V189, P2186, DOI 10.1016/j.juro.2012.12.022
  134. Karram MM, 2009, UROLOGY, V73, P14, DOI 10.1016/j.urology.2008.08.485
  135. Finazzi-Agro E, 2010, J UROLOGY, V184, P2001, DOI 10.1016/j.juro.2010.06.113
  136. GAJEWSKI JB, 1986, J UROLOGY, V135, P966
  137. Vella M, 2011, EXPERT OPIN DRUG SAF, V10, P805, DOI 10.1517/14740338.2011.591377
  138. Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024
  139. Malone-Lee JG, 2009, BJU INT, V103, P931, DOI 10.1111/j.1464-410X.2009.08361.x
  140. Arrabal-Polo Miguel Angel, 2012, Korean J Urol, V53, P483, DOI 10.4111/kju.2012.53.7.483
  141. Biemans JM, 2013, NEUROMODULATION, V16, P33
  142. Chancellor MB, 2014, UROL PRACT, V1, P7
  143. Chartier-Kastler E, 2011, Prog Urol, V21, P209, DOI 10.1016/j.purol.2010.05.008
  144. Colombo M, 1995, INT UROGYNECOL J, V6, P63, DOI 10.1007/BF01962573
  145. Drutz H P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P283, DOI 10.1007/s001929970003
  146. Fader M, 2007, J UROLOGY, V177, P208, DOI 10.1016/j.juro.2006.08.099
  147. Gaziev G, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-61
  148. Geoffrion Roxana, 2012, J Obstet Gynaecol Can, V34, P1092
  149. Giannitsas K, 2004, EUR UROL, V46, P782
  150. Halaska M., 2003, World Journal of Urology, V20, P392
  151. Homma Y, 2004, BJU INT, V93, P1135
  152. Jayarajan Jyotsna, 2013, Res Rep Urol, V6, P1, DOI 10.2147/RRU.S40034
  153. Kanie S, 2012, UROLOGY, V79
  154. Kessler TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016718
  155. Lee Raymond T, 2013, Res Rep Urol, V5, P147, DOI 10.2147/RRU.S38792
  156. Madhuvrata P, 2012, COCHRANE DB SYST REV, V1
  157. Pagoria Dustin, 2011, Curr Urol Rep, V12, P351, DOI 10.1007/s11934-011-0198-9
  158. Roxburgh C, 2007, COCHRANE DB SYST REV, V4
  159. Roxburgh C, 2007, COCHRANE DB SYST REV, V3
  160. Staskin D, 2007, J UROLOGY, V178, P983
  161. Veeratterapillay R, 2014, INT J UROL, V21, P175, DOI 10.1111/iju.12205
  162. Wagg A., 2012, EUR UROL REV, V7, P42

Coleções
Artigos e Materiais de Revistas Científicas - HC/IOT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/55